VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL

被引：0
|
作者：
Pourhadi, H. [1 ]
Johnson, A. [1 ]
Foote, A. [1 ]
机构：
[1] Northern Hlth, Rheumatol, Epping, NSW, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
COVID; bDMARD; Vaccination/Immunization;
D O I：
10.1136/annrheumdis-2023-eular.5416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1812-HPR
引用
收藏
页码：2139 / 2139
页数：1
相关论文
共 50 条
  • [21] Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs
    Taroumian, Sara
    Knowles, Susan L.
    Lisse, Jeffrey R.
    Yanes, James
    Ampel, Neil M.
    Vaz, Austin
    Galgiani, John N.
    Hoover, Susan E.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (12) : 1903 - 1909
  • [22] An Update of Management of Coccidioidomycosis in Patients On Biologic Response Modifiers and Disease-Modifying Antirheumatic Drugs
    Knowles, Susan
    Sudano, Dominick
    Taroumian, Sara
    Ampel, Neil M.
    Galgiani, John
    Lisse, Jeffrey R.
    Hoover, Susan E.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S919 - S919
  • [23] SAFETY AND EFFECTIVENESS OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITI
    Freitas, Raquel
    Fonseca, Joao Eurico
    Polido-Pereira, Joaquim
    Madeira, Nathalie
    Miranda, Luis Cunha
    Bernardes, Miguel
    Fernandes, Bruno Miguel
    Costa, Flavio
    Santiago, Mariana
    Neto, Agna
    Azevedo, Soraia
    Dias, Joao Madruga
    Couto, Mara
    Sequeira, Graca
    Santos, Maria Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1142 - 1143
  • [24] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [25] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [26] Annual Cost of Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
    Hosseini, Roya
    Brown, Lawrence
    Fleming, Marc
    Rodriguez-Monguio, Rosa
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2161 - 2162
  • [27] Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma
    Calip, Gregory S.
    Patel, Pritesh R.
    Sweiss, Karen
    Wu, Zhaoju
    Zhou, Jifang
    Asfaw, Alemseged A.
    Adimadhyam, Sruthi
    Lee, Todd A.
    Chiu, Brian C-H
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (05) : 1300 - 1305
  • [28] THE EFFECT OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (bDMARDs) IN TARGETING DISEASE REMISSION IN AXIAL SPONDYLOARTHRITIS (axSpA): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Cruz-Machado, A. R.
    Manica, S. R.
    Silva, J. L.
    Pimentel-Santos, F. M.
    Tavares-Costa, J.
    Vieira-Sousa, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 731 - 731
  • [29] Modern disease-modifying antirheumatic drugs
    Mueller-Ladner, U.
    Richter, K.
    Tarner, I. H.
    INTERNIST, 2015, 56 (03): : 307 - 314
  • [30] Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
    Adami, Giovanni
    Fassio, Angelo
    Rossini, Maurizio
    Bertelle, Davide
    Pistillo, Francesca
    Benini, Camilla
    Viapiana, Ombretta
    Gatti, Davide
    RMD OPEN, 2023, 9 (01):
12345